Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Equity (2021 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Return on Equity for 5 consecutive years, with 1.22% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 63.0% to 1.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.22% through Dec 2025, down 63.0% year-over-year, with the annual reading at 0.87% for FY2025, 38.0% down from the prior year.
  • Return on Equity hit 1.22% in Q4 2025 for Rapid Micro Biosystems, down from 0.9% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.11% in Q2 2021 to a low of 1.22% in Q4 2025.
  • Historically, Return on Equity has averaged 0.48% across 5 years, with a median of 0.43% in 2023.
  • Biggest five-year swings in Return on Equity: skyrocketed 63bps in 2022 and later tumbled -63bps in 2025.
  • Year by year, Return on Equity stood at 0.32% in 2021, then dropped by -10bps to 0.35% in 2022, then dropped by -20bps to 0.43% in 2023, then plummeted by -38bps to 0.59% in 2024, then crashed by -107bps to 1.22% in 2025.
  • Business Quant data shows Return on Equity for RPID at 1.22% in Q4 2025, 0.9% in Q3 2025, and 0.73% in Q2 2025.